Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors

Patent 10251892 was granted and assigned to Incyte on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
Edits on 3 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12024517 Salts of an FGFR inhibitor
0
Edits on 19 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 29 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+246 characters)
Article

Patent abstract

The present disclosure relates to bicyclic heterocycles of Formula (I′), and pharmaceutical compositions of the same, that are inhibitors of the FGFR3 and/or FGFR4 enzyme and are useful in the treatment of FGFR-associated diseases.

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Alexander Sokolsky0
Liangxing Wu0
Wenqing Yao0
Edits on 7 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11667635 Bicyclic heterocycles as FGFR4 inhibitors
0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 19 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11628162 Methods of treating cancer with an FGFR inhibitor
0
Edits on 11 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11607416 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 29 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102518920
Date of Patent
April 9, 2019
0
Patent Application Number
156276650
Date Filed
June 20, 2017
0
Patent Citations Received
‌
US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same
0
‌
US Patent 10632126 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10738048 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10813930 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
0
‌
US Patent 10851105 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10947230 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11014923 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 11053246 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 11407750 Derivatives of an FGFR inhibitor
0
‌
US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same
0
‌
US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same
0
‌
US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11566028 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11591329 Bicyclic heterocycles as FGFR inhibitors
0
Patent Primary Examiner
‌
Jeffrey H Murray
0

Find more entities like US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo